Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top EstimatesPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates

Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.14 per share a year ago

Distribution Solutions Group (DSGR) Surpasses Q2 Earnings and Revenue Estimates
Distribution Solutions Group (DSGR) Surpasses Q2 Earnings and Revenue Estimates

Distribution Solutions Group (DSGR) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.35 per share a year

Koppers (KOP) Q2 Earnings and Revenues Beat Estimates
Koppers (KOP) Q2 Earnings and Revenues Beat Estimates

Koppers (KOP) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.48 per share a year ago. These figures are

Kelly Services (KELYA) Q2 Earnings and Revenues Beat Estimates
Kelly Services (KELYA) Q2 Earnings and Revenues Beat Estimates

Kelly Services (KELYA) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.54 per share a year ago. These

ITT (ITT) Tops Q2 Earnings and Revenue Estimates
ITT (ITT) Tops Q2 Earnings and Revenue Estimates

ITT (ITT) came out with quarterly earnings of $2.08 per share, beating the Zacks Consensus Estimate of $1.93 per share. This compares to earnings of $1.64 per share a year ago. These figures are

Globalstar (GSAT) Reports Q2 Loss, Lags Revenue Estimates
Globalstar (GSAT) Reports Q2 Loss, Lags Revenue Estimates

Globalstar (GSAT) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.13 per share a year ago. These figures are

Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.16 per share a year ago

Installed Building Products (IBP) Q2 Earnings and Revenues Surpass Estimates
Installed Building Products (IBP) Q2 Earnings and Revenues Surpass Estimates

Installed Building Products (IBP) came out with quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.95 per share a year

Hertz Global Holdings, Inc. (HTZ) Reports Q2 Loss, Beats Revenue Estimates
Hertz Global Holdings, Inc. (HTZ) Reports Q2 Loss, Beats Revenue Estimates

Hertz Global Holdings, Inc. (HTZ) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.34 per share a year ago

Ocugen (OCGN) Reports Q2 Loss, Beats Revenue Estimates
Ocugen (OCGN) Reports Q2 Loss, Beats Revenue Estimates

Ocugen (OCGN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.05 per share a year ago. These figures are

Shift4 Payments (FOUR) Q2 Earnings and Revenues Beat Estimates
Shift4 Payments (FOUR) Q2 Earnings and Revenues Beat Estimates

Shift4 Payments (FOUR) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.1 per share a year ago. These

Payoneer Global Inc. (PAYO) Misses Q2 Earnings Estimates
Payoneer Global Inc. (PAYO) Misses Q2 Earnings Estimates

Payoneer Global Inc. (PAYO) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago

Frontdoor (FTDR) Q2 Earnings and Revenues Top Estimates
Frontdoor (FTDR) Q2 Earnings and Revenues Top Estimates

Frontdoor (FTDR) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.63 per share a year ago. These figures

Fox Corporation (FOX) Surpasses Q4 Earnings and Revenue Estimates
Fox Corporation (FOX) Surpasses Q4 Earnings and Revenue Estimates

Fox Corporation (FOX) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.27 per share a year ago. These

Fox (FOXA) Q4 Earnings and Revenues Surpass Estimates
Fox (FOXA) Q4 Earnings and Revenues Surpass Estimates

Fox (FOXA) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.27 per share a year ago. These figures are

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $0.57 per share a year

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.28 per share a year ago. These

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.33 per share a year ago. These

Monte Rosa Therapeutics (GLUE) Reports Q2 Loss, Misses Revenue Estimates
Monte Rosa Therapeutics (GLUE) Reports Q2 Loss, Misses Revenue Estimates

Monte Rosa Therapeutics (GLUE) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.15 per share a year ago. These

FrontView REIT, Inc. (FVR) Q2 FFO Meet Estimates
FrontView REIT, Inc. (FVR) Q2 FFO Meet Estimates

FrontView REIT, Inc. (FVR) came out with quarterly funds from operations (FFO) of $0.33 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.32 per share a year ago